Rationale: Mitochondria constitute 30% of myocardial mass. Mitochondrial fusion and fission appear essential for health of most tissues. Mitochondrial fission occurs in neonatal cardiomycyte and is implicated in cardiomyocyte death. Mitochondrial fusion has not been observed in postmitotic myocytes of adult hearts, and its occurrence and function in this context are controversial.
M itochondrial fusion and fission are evolutionarily conserved mechanisms that promote mitochondrial health via exchange of mitochondrial proteins, lipids, and genomes. Dilution of senescent enzymes and mutated mitochondrial DNA is a reparative process for dysfunctional organelles. Subsequent mitochondrial fission restores normal mitochondrial morphology and contributes to mitochondrial health by packaging damaged mitochondrial components into a daughter organelle that is eliminated. 1 Mitochondrial fusion is mediated by several GT-Pases: mitofusins (Mfn) 1 and 2 on the outer mitochondrial membrane, and optic atrophy 1 (Opa1) on the inner mitochondrial membrane. Loss of function mutations of these mitochondrial fusion proteins produces the degenerative neurological disease Charcot Marie Tooth Syndrome Type 2A (Mfn2 mutations) and autosomal dominant optic atrophy (Opa1 mutations). 2 Heart disease is not a factor of these conditions, 3 suggesting that mitochondrial fusion may be dispensable in the heart. Indeed, whereas mitochondrial fission has been observed and implicated in programmed death or differentiation of cardiac myocytes, 4,5 mitochondrial fusion has not been described in adult cardiac myocytes, and there is controversy over whether it occurs. 6 Cardiac deletion of Mfn2 had little effect on normal hearts and appeared protective after ischemic damage, 7 but Mfn1 can induce mitochondrial fusion in the absence of Mfn2 8 ; without both mitofusins organelle fusion does not occur. Thus, we engineered genetic mouse models in which both mitofusins are ablated in cardiac myocytes of either mouse early embryos or adults.
Methods
Detailed methods are in the Online Supplement, available at http://circres.ahajournals.org.
Results
We ablated murine cardiomyocyte mfn1 and mfn2 using floxed allele mice 9 ( Figure 1A ) crossed onto Nkx2.5 Cre 10 that promotes gene recombination in the embryonic mouse heart ( Figure  1B expected Mendelian ratios ( Figure 1C ). In contrast, Mfn1/Mfn2 double cardiac knockout mice (DKO) were not observed at birth, with lethality between e9.5 and e10.5 ( Figure 1C ). Thus, expression of either Mfn1 or Mfn2 in embryonic hearts is sufficient for viability, but absence of both is incompatible with life.
To avoid embryonic lethality, cardiac Mfn1/Mfn2 DKO mice were generated using a tamoxifen-inducible modified estrogen receptor (MER) cardiac-specific MYH6-Cre transgene 11 ( Figure  2A ). Mfn cardiac DKO mice were born at expected Mendelian ratios and survived normally. Three weeks after tamoxifen induction (8-week-old mice), cardiac Mfn1 and Mfn2 immunoreactivities were decreased by Ͼ80% ( Figure 2B ). The inner mitochondrial fusion protein Opa1 was modestly upregulated in Mfn1/Mfn2 DKO hearts, whereas the mitochondrial fission protein DRP1 was unaffected ( Figure 2B) .
The time course of tamoxifen-mediated cardiac gene ablation was assessed using the ROSA26 lacZ marker gene ( Figure 2C ). Gene recombination (blue-stained myocardium) was evident 1 day after the first tamoxifen dose, was observed throughout the heart on day 3, and was uniform and intense on day 7.
We determined the consequence of mitofusin deficiency on mitochondrial morphology using flow cytometry of cardiac mitochondria 3 weeks after tamoxifen-induced mfn1/mfn2 gene deletion. Forward scattered light measures mitochondrial size and side-scattered light measures complexity of shape. Histograms of forward scatter showed the typical normal distribution of mitochondrial size in control hearts ( Figure 2D , left; black line), but a leftward shift and loss of normal size distribution in Mfn cardiac DKO hearts ( Figure  2D , left; red line). Mitochondrial size was decreased Ϸ40% (forward scatter; Pϭ0.002) ( Figure 2D , middle) and shape complexity was decreased Ϸ60% (side scatter; Pϭ0.001) ( Figure 2D , right). Mitochondrial protein content of Mfn cardiac DKO hearts was approximately twice that of controls ( Figure 2E , Pϭ0.0026), similar to findings in skeletal muscle Mfn DKO mice 16 ; the mechanism for "proliferation" of fusion-defective mitochondria is currently unknown.
These results suggest that loss of adult cardiomyocyte Mfn proteins results in a plethora of small, round mitochondria. Ultrastructural studies confirmed this interpretation and further revealed abnormal or degenerated mitochondrial cristae in Mfn cardiac DKO cardiomyocytes ( Figure 2F ). This form of mitochondrial dysmorphology is referred to as mitochondrial "fragmentation," although it is actually the result of mitochondrial fission unopposed by normal fusion. 9 Mfn1/Mfn2-deficient cardiomyocytes exhibited diminished ADP-stimulated O 2 consumption and decreased maximal O 2 consumption of uncoupled isolated DKO mitochondria ( Figure 2H ), revealing impaired respiration ( Figure 2G ). Thus, mitochondrial fusion mediated by Mfn1 or Mfn2 is essential for normal cardiac mitochondrial morphology and respiratory function.
Our studies were designed to interrupt mitochondrial fusion in adult mouse hearts. Because Mfn2 is also implicated in tethering mitochondria to endoplasmic reticulum and altered mitochondrial-reticular interactions could theoretically affect cytosolic calcium, 8, 12 we measured cytosolic calcium in DKO cardiomyocytes. Both contractility ( Figure  3A ) and cytosolic calcium transients ( Figure 3B ) were normal in Mfn cardiac DKO cardiomyocytes 1 week after tamoxifen treatment. Thus, combined Mfn1 and Mfn2 ablation does not primarily affect cardiomyocyte excitation-contraction coupling.
Cardiomyocyte mitochondrial dysmorphology, impaired cellular respiration, and the early lethal phenotype of embryonic cardiac Mfn1/Mfn2 ablation suggested that disrupting cardiomyocyte mitochondrial fusion might have pathological consequences, given sufficient time. Therefore, we serially interrogated cardiac structure and function after combined mfn1/mfn2 gene ablation induced by tamoxifen. Compared to littermate controls (tamoxifen-treated floxed allele mice without Cre), cardiac Mfn DKO hearts were normal 1 week after tamoxifen, but progressively dilated during the subsequent 5 weeks ( Figure 4A ). Conditional combined mfn1 and mfn2 ablation with Raloxifene 13 resulted in a similar progressive dilated cardiomyopathy, although the time course was slightly delayed ( Figure 4B ). Signs of overt heart failure (rapid respirations, decreased movement) were observed after 7 to 8 weeks, and the mice succumbed shortly thereafter.
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Discussion
We used conditional cardiac-specific combined ablation of Mfn1 and Mfn2 to demonstrate that mammalian hearts have the same requirement for mitochondrial fusion as Drosophila heart tubes and murine brain and skeletal muscle. 9,14 -16 When the mitochondrial fusion apparatus was disrupted in adult hearts, cardiomyocyte mitochondria "fragmented," whole cardiomyocyte and isolated mitochondrial respiration were compromised, and the hearts dilated and failed over a period of weeks. These results prove that mitochondrial morphological and functional integrity requires an intact fusion/fission apparatus. Although mitochondrial fission can be increased in programmed cardiomyocyte death, 17 unopposed mitochondrial fission was not associated with increased cardiomyocyte TUNEL positivity or sensitivity of the permeability transition pore to calcium (Online Figure) . Our findings are similar to a recent report of combined Mfn1/Mfn2 deletion in murine skeletal muscle. 16 Indeed, mito- chondrial fragmentation, cellular respiratory dysfunction, and myopathy are features of both the cardiac and skeletal musclespecific Mfn1/Mfn2 double knockout mice. Thus, although adult cardiac myocytes are postmitotic and their mitochondria are limited in motility and physically constrained between myofila-ments, the heart is not an exception to the general rule that mitochondrial fusion is important to cellular and tissue health. Because we used inducible double gene ablation, our data permit us to estimate the rate of in vivo mitochondrial fusion in adult cardiac myocytes. This calculation assumes that steady- state mitochondrial fusion and fission are balanced in normal hearts and that the rate of mitochondrial fission does not change after Mfn1/Mfn2 ablation. Unopposed fission will decrease mitochondrial population size over time in a geometric relationship. Cre-mediated gene excision was complete 1 week after tamoxifen, and mitochondrial size decreased by Ϸ40% 2 weeks thereafter. Thus, a cardiomyocyte mitochondrial fusion/fission cycle takes approximately 16 days. Lethal heart failure observed 7 to 8 weeks after Mfn1/Mfn2 ablation therefore corresponds to 3 to 4 cycles of unopposed mitochondrial fission.
Mitofusins are regulated in cardiac disease or cardiomyocyte injury. 18 -20 Our results suggest that decreased mitofusin expression or function has the potential to contribute to cardiac pathology by interfering with essential mechanics of mitochondrial fission/fusion.
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Novelty and Significance
What Is Known?
• Myocardium is the most mitochondria-rich tissue. • In most tissues mitochondria periodically tether, fuse, exchange organelle contents, and divide. • Mitochondrial fusion has not been observed in vertebrate hearts; its existence in this context is disputed and its role (if any) is unknown.
What New Information Does This Article Contribute?
• By combinatorially ablating the genes encoding outer mitochondrial membrane fusion proteins, Mfn1 and Mfn2, in embryonic or adult mouse hearts, we interrupted mitochondrial fusion in cardiomyocytes. • Mitofuscin-deficient adult heart cells contained unusually small mitochondria with structurally abnormal cristae and exhibited respiratory compromise.
• Interrupting mitochondria fusion in either embryonic or adult hearts proved lethal, in the latter case inducing rapidly progressive cardiac remodeling.
Mitochondria are engines that fuel cardiac contraction and mediators of programmed cardiomyocyte death. In many tissues, mitochondria cyclically tether to each other, fuse, and divide, thereby exchanging constituent proteins and nucleic acids. The highly organized intracellular architecture of cardiomyocytes enforces close mitochondrial approximation, suggesting that tethering may be irrelevant and fusion functionally unimportant. Compound genetic deletion of mitofusins that mediate mitochondrial tethering and fusion in embryonic and adult hearts proved lethal, inducing organelle fragmentation from unopposed fission, respiratory compromise, and rapidly progressive dilated cardiomyopathy without programmed cardiomyocyte death. Thus, mitochondrial fusion is essential to vertebrate cardiac health.
